Last updated on June 2018

Placebo-controlled efficacy and safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Complex Regional Pain Syndrome- type 1 (CRPS-I)
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

  • A diagnosis of CRPS according to the clinical diagnostic criteria recommended by the International Association for the Study of Pain (IASP; “Budapest clinical criteria”), assessed at Visit 1.
  • Signs and symptoms of CRPS must apply to an affected limb (arm or leg) and must demonstrate asymmetry with respect to the contralateral limb.
  • The CRPS duration must be 2 years or less since onset of symptoms.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.